ADVFN ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Euroapi SA

Euroapi SA (EAPI)

1.244
0.02
( 1.63% )
Actualizado: 02:14:57

Euroapi SA (EAPI) Cotización

Herramientas de nivel profesional para inversores individuales.

Premium

Estadísticas y detalles clave

Último Precio
1.244
( 1.63% )
Postura de Compra
1.228
Postura de Venta
1.244
Volume Operado de la Acción
6,597
1.222 Rango del Día 1.246
1.22 Rango de 52 semanas 3.438
Capitalización de Mercado [m]
Precio Anterior
1.224
Precio de Apertura
1.222
Última hora de negociación
02:15:22
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
156,857 €
Acciones en circulación
95,187,906
Rendimiento del Dividendo (LTM)
Ratio Precio/Utilidad
-0.56
Beneficio por acción (BPA)
-2.23
turnover
852.6M
Beneficio neto
-211.2M

Acerca de Euroapi SA

Euroapi S.A. develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use in France, Europe, Rest of Europe, North America, the Asia Pacific, and internationally. The company offers contract dev... Euroapi S.A. develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use in France, Europe, Rest of Europe, North America, the Asia Pacific, and internationally. The company offers contract development manufacturing organization for different classes of tides that uses solid phase chemistry; particle engineering; microbial fermentation; small molecules synthesis; prostaglandins; steroids and hormones; and opiates and controlled substances. It provides their products to pharmaceutical, generic drug manufacturers, animal health product manufacturers, consumer health, nutrition and cosmetic product companies, biotech companies, and distribution companies, as well as contract development and manufacturing organization. The company has a strategic alliance with Abolis Biotechnologies SAS for the development of microbial strains for the synthesis of key intermediates and 20 active ingredients. Euroapi S.A. was incorporated in 2020 and is based in Paris, France. Mostrar más

Sector
Healthcare
Industria
Pharmaceuticals
Sitio web
Sede
Paris, France
Fundado
2026
Euroapi SA is listed in the Healthcare sector of the Euronext with ticker EAPI. The last closing price for Euroapi was 1.22 €. Over the last year, Euroapi shares have traded in a share price range of 1.22 € to 3.438 €.

Euroapi currently has 95,187,906 shares in issue. The market capitalisation of Euroapi is 118.41 € million. Euroapi has a price to earnings ratio (PE ratio) of -0.56.

EAPI Últimas noticias

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.008-0.6389776357831.2521.2861.222808811.2378148DE
4-0.228-15.48913043481.4721.4941.2221254641.32175126DE
12-0.04-3.115264797511.2841.5721.2221528821.37005876DE
26-0.936-42.93577981652.182.2741.222077231.57685565DE
52-1.722-58.05799055972.9663.4381.221737152.12747296DE
156-9.216-88.107074569810.4612.971.222529464.12184268DE
260-11.256-90.04812.519.0151.222960727.98885902DE

EAPI - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Euroapi SA?
El precio actual de las acciones de Euroapi SA es 1.244 €
¿Cuántas acciones de Euroapi SA están en circulación?
Euroapi SA tiene 95,187,906 acciones en circulación
¿Cuál es la capitalización de mercado de Euroapi SA?
La capitalización de mercado de Euroapi SA es EUR 118.41M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Euroapi SA?
Euroapi SA ha negociado en un rango de 1.22 € a 3.438 € durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Euroapi SA?
El ratio precio/beneficio de Euroapi SA es -0.56
¿Cuál es el ratio de efectivo a ventas de Euroapi SA?
El ratio de efectivo a ventas de Euroapi SA es 0.14
¿Cuál es la dirección registrada de Euroapi SA?
La dirección registrada de Euroapi SA es 15 Rue Traversiere, Paris, Ile-de-France, 75012
¿Cuál es la dirección del sitio web de Euroapi SA?
La dirección del sitio web de Euroapi SA es www.euroapi.com/en
¿En qué sector industrial opera Euroapi SA?
Euroapi SA opera en el sector Pharmaceuticals

EAPI Operaciones

Más

Operaciones con retraso

Para obtener operaciones en tiempo real, actualice su cuenta

Actualizar a tiempo real
nowwhat2 nowwhat2 8 minutos hace
Remarkable reporting (if I do say so myself) he-he

https://investorshub.advfn.com/uimage/uploads/2026/6/23/ysrgibtc_june_22_1m_1045pm_SUMMARY_66666_FOMC_GUTSY.jpg

:45 minutes later and.....
https://investorshub.advfn.com/uimage/uploads/2026/6/23/guikmbtc_june_2
SMA
US Market News US Market News 18 minutos hace
LiveRamp Partners with Adobe to Bring Commerce Purchase Data into GenStudio for Commerce Media NetworksJune 23, 2026 3:00 AM
Business WireAdobe GenStudio for Commerce Media Networks addresses key creative, data, and activation needsLiveRamp (NYSE: RAMP),
RAMP
US Market News US Market News 19 minutos hace
AbbVie Announces European Commission Approval of SKYRIZI® (risankizumab) for the Treatment of Pediatric Patients with Moderate to Severe Plaque PsoriasisJune 23, 2026 3:00 AM
PR Newswire (US) SKYRIZI® (risankizumab) expands i
ABBV
US Market News US Market News 19 minutos hace
AbbVie Announces European Commission Approval of SKYRIZI® (risankizumab) for the Treatment of Pediatric Patients with Moderate to Severe Plaque PsoriasisJune 23, 2026 3:00 AM
PR Newswire (US) SKYRIZI® (risankizumab) expands i
ABBV
US Market News US Market News 19 minutos hace
Clarivate Releases 2025 Sustainability ReportJune 23, 2026 3:00 AM
PR Newswire (US) New report highlights progress against goals and a decline in total carbon emissions class="legendSpanClass"LONDON, class="legendSpanClass"June 23, 2026
CLVT
nowwhat2 nowwhat2 26 minutos hace
Remarkable reporting (if I do say so myself) he-he

https://investorshub.advfn.com/uimage/uploads/2026/6/23/ysrgibtc_june_22_1m_1045pm_SUMMARY_66666_FOMC_GUTSY.jpg

:45 minutes later and.....
https://investorshub.advfn.com/uimage/uploads/2026/6/23/guikmbtc_june_2
BTCUSD
WooptdooU WooptdooU 27 minutos hace
Seeking Alpha article is INCREDIBLY POSITIVE, just read it!!!
It is written Nearly ALL POSITIVE facts and negative opinion, just a real whimper level of faith, trust and risk tolerance. It is also Just incredible to read the nearly bear case scenario of present value pricing lists a HIGHER pr
LWLG
US Market News US Market News 34 minutos hace
Tradeweb Launches Spread Trading for European Credit PortfoliosJune 23, 2026 3:00 AM
Business Wire Enables portfolio-level execution on a spread within a single, integrated workflow Tradeweb Markets Inc. (Nasdaq: TW), a global leader in electronic tradi
TW
shajandr shajandr 36 minutos hace
As usual, you're a funny guy.

Like a clown.

https://www.youtube.com/watch?v=Pfcy15ZUE2c
Tom turtles Tom turtles 36 minutos hace
What a monster.....Holding 50k from .,28
OTLK
Ray_137 Ray_137 38 minutos hace
So now Jack fruit in July.
RKT
FORDGT FORDGT 49 minutos hace
Significant Failures to Deliver
Yes
ADTX
RuudSaltis RuudSaltis 49 minutos hace
Shorts will be active this weak spreading fear and doubt!
LWLG
mdb1 mdb1 60 minutos hace
is US stock market going to "crash" tomorrow???????
TSLA
One11 One11 1 hora hace
Gonna be a long wait, imo. Tech has to catch itself. Could be the Winner but other tech could suffice or be realized in the next couple years. LWLG could score a nice foothold for a space in the industry, to me this has legit promise and already is in the door, so to speak , but the results need
LWLG
Henk van vleuten Henk van vleuten 1 hora hace
Is it really possible to get back to $18 in the short term, or is this more of a “be patient until June 2027” story? I’m genuinely curious what everyone thinks. Here are my main dilemmas:

* Waiting for the tape-outs and the Telcordia GR-468 chip test results.
* Are we in Marvel
LWLG
US Market News US Market News 1 hora hace
TotalEnergies SE: Disclosure of Transactions in Own SharesJune 23, 2026 2:00 AM
Business Wire Regulatory News: In accordance with the authorizations given by the shareholders’ general meeting on May 29, 2026, to trade on its shares and pursuant to applicable law on shar
TTE
US Market News US Market News 1 hora hace
Omnicom Launches Acxiom Fan Graph to Give Brands a More Complete View of Sports FandomJune 23, 2026 2:00 AM
PR Newswire (US) New sports marketing intelligence solution unifies fan data across media, commerce, and consumer engagement class="legend
OMC
US Market News US Market News 1 hora hace
Keurig Dr Pepper Announces Leadership UpdatesJune 23, 2026 2:00 AM
PR Newswire (US) class="legendSpanClass"FRISCO, Texas and BURLINGTON, Mass., class="legendSpanClass"June 23, 2026 /PRNewswire/ -- Keurig Dr Pepper Inc. (NASDAQ: KDP) toda
KDP
shajandr shajandr 1 hora hace
First, GEORGE (HELISCHAUER) SHARP, now ALAN GREENSPAN. Who will be the third legendary titan of finance to die and complete the trifecta? SOROS? BUFFETT? PETER LYNCH? ANDREW FASSARI (aka "OCMillionaire")? JERRY S. WILLIAMS (aka "Monk" of Monk's Den)? LEWIS ("Lew") RANIERI? WILLIAM H. ("Bill") GROSS?
SPCX
Seminole Red Seminole Red 1 hora hace
Here is the weekend TV schedule for the NASCAR Cup Series, NASCAR O'Reilly Auto Parts Series, and ARCA Menards Series races at Sonoma Raceway.

https://scontent-mia3-3.xx.fbcdn.net/v/t39.99422-6/730517954_1328853052789840_6212596854535899855_n.png?stp=dst-jpg_tt6&cstp=mx1024x1284&ctp=s
bbotcs bbotcs 1 hora hace
r59: INTU correction: $257 not 275. It was $256 and change in after-hours trading.
Very unloved by institutional investors at the moment.
INTU
AlwaysKing AlwaysKing 1 hora hace
$BCDS ~ABSOLUTELY INCREDIBLE! Those numbers are amazing and just the very beginning, the tip of the iceberg. As ALL 25 APPS and UTILITIES they've launched GLOBALLY CONTINUE GROWING in POPULARITY and becoming MASS ADOPTED RAPIDLY the REVENUE STREAMS WILL CONTINUE GROWING EXPONENTIALLY also!!! So AW
BCDS
bbotcs bbotcs 2 horas hace
SSKILLZ1: INTU
It is an unloved stock in an unloved tech sector.
Good observation.
I am still watching. I'd love to buy shares of INTU near the 52-week low. Wishful thinking.
INTU
RuudSaltis RuudSaltis 2 horas hace
The timing and predictions of Seeking Alpha are really interesting. In general a negative article means we are about to be launced very soon. In many cases, just days, the share skyrockets! (I made a fortune on Gamestop and ACM when they recommended to sell as quick as possible!).
And placing
LWLG